id,agency_id,docket_id,title,document_type,subtype,posted_date,posted_year,posted_month,comment_start_date,comment_end_date,last_modified,fr_doc_num,open_for_comment,withdrawn,object_id
FDA-2010-E-0654-0003,FDA,FDA-2010-E-0654,FDA/CDER to U.S. Patent and Trademark Office - Letter,Other,Letter(s),2012-03-06T05:00:00Z,2012,3,2012-03-06T05:00:00Z,,2012-03-06T13:37:40Z,,0,0,0900006480fcfbe8
FDA-2010-E-0654-0002,FDA,FDA-2010-E-0654,U.S Patent and Trademark Office to FDA - Letter,Other,LET-Letter,2010-12-29T05:00:00Z,2010,12,2010-12-29T05:00:00Z,,2013-07-27T23:41:17Z,,0,0,0900006480bc2342
FDA-2010-E-0654-0001,FDA,FDA-2010-E-0654,"Gilead Sciences, Inc. - Patent Term Extension Application",Other,APP-Application,2010-12-29T05:00:00Z,2010,12,2010-12-29T05:00:00Z,,2013-07-27T23:41:17Z,,0,0,0900006480bc225b